Acorah Software Products - Accounts Production 19.3.550 false true 31 March 2025 1 April 2024 false 1 April 2025 31 March 2026 31 March 2026 12349166 Dr NA Kotnis Dr SV Kotnis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12349166 2025-03-31 12349166 2026-03-31 12349166 2025-04-01 2026-03-31 12349166 frs-core:CurrentFinancialInstruments 2026-03-31 12349166 frs-core:ShareCapital 2026-03-31 12349166 frs-core:RetainedEarningsAccumulatedLosses 2026-03-31 12349166 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 12349166 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 12349166 frs-bus:SmallEntities 2025-04-01 2026-03-31 12349166 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 12349166 frs-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 12349166 frs-bus:Director1 2025-04-01 2026-03-31 12349166 frs-bus:Director2 2025-04-01 2026-03-31 12349166 frs-countries:EnglandWales 2025-04-01 2026-03-31 12349166 2024-03-31 12349166 2025-03-31 12349166 2024-04-01 2025-03-31 12349166 frs-core:CurrentFinancialInstruments 2025-03-31 12349166 frs-core:ShareCapital 2025-03-31 12349166 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31
Registered number: 12349166
NAS RadMed Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2026
NAS RadMed Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
NAS RadMed Ltd
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 12349166

| 2026 | 2025
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Debtors | 4 | 4,189 |  | 2,602 |
Cash at bank and in hand |  | 147,726 |  | 109,088 |
|  | 151,915 |  | 111,690 |
Creditors: Amounts Falling Due Within One Year | 5 | (22,167 ) |  | (16,178 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 129,748 |  | 95,512
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 129,748 |  | 95,512
NET ASSETS |  |  | 129,748 |  | 95,512
CAPITAL AND RESERVES
Called up share capital | 6 |  | 200 |  | 200
Profit and Loss Account |  |  | 129,548 |  | 95,312
SHAREHOLDERS' FUNDS |  |  | 129,748 |  | 95,512

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr NA Kotnis Director
06/07/2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
NAS RadMed Ltd
Notes to the Financial Statements
For The Year Ended 31 March 2026
Notes to the Financial Statements
1. General Information
NAS RadMed Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12349166 . The registered office is 126 Townhead Road, Sheffield, S17 3GB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
- -
4. Debtors

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 4,189 |  | 2,602

5. Creditors: Amounts Falling Due Within One Year

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Corporation tax | 8,265 |  | 8,613
Accruals and deferred income | 898 |  | 892
Directors' loan accounts | 13,004 |  | 6,673
| 22,167 |  | 16,178

6. Share Capital

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 200 |  | 200

Page 2